This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

CandiZYME (2013-10-20)

Starting date:
October 20, 2013
Posting date:
November 21, 2013
Type of communication:
Drug Recall
Subcategory:
Natural health products
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-36697

Recalled Products 

CandiZYME

Reason

The product may contain the drug ingredient chloramphenicol.

Depth of distribution

National retail distribution.

Affected products

CandiZYME 

DIN, NPN, DIN-HIM
NPN 80036437
Dosage form

Capsules

Strength
  • 1,3-beta-D-xylan xylanohydrolase  37.5 mg 15000.0 FCC HCU
  • 1,4-alpha-D-Glucan glucohydrolase  50.0 FCC AGU 50.0 mg
  • 4-(1,3;1,4)-beta-D-Glucan 4-glucanohydrolase  250.0 mg 37500.0 FCC CU
  • 4-alpha-D-Glucan glucanohydrolase  60.0 mg 6000.0 FCC DU
  • Beta-galactosidase  2.5 mg 250.0 FCC ALU
  • Malt diastase  12.5 mg 125.0 FCC DP
  • N- Acetylmuramyl hydrolase  7.5 FCC LU 7.5 mg
  • Protease  200.0 mg 100000.0 FCC HUT
  • Triacylglycerol acylhydrolase  6.5 mg 500.0 FCC LU
  • beta-D-fructofuranoside fructohydrolase  3.5 mg 350.0 FCC SU
Lot or serial number
  • 2526300
Companies
Recalling Firm
Renew Life Canada
8-1273 North Service Road
Oakville
L6H 1A7
Ontario
CANADA
Marketing Authorization Holder
Renew Life Canada
8-1273 North Service Road
Oakville
L6H 1A7
Ontario
CANADA

Date modified: